Long-term benzodiazepine tapering is notoriously difficult, and clinician time is limited. A VA-based randomized trial tests whether a free, self-guided website alone can help patients successfully cut down or stop.

Should medications for pediatric bipolar disorder ever be reduced or stopped? This update reviews relapse risk after discontinuation, how bipolar I differs from bipolar II, and a stepwise approach to minimizing antipsychotic exposure—covering patient selection, taper pacing, and the role of adjunctive psychotherapy.

Adult tapering rules don’t always translate cleanly to children and teens. A new systematic review asks which antidepressants carry the highest withdrawal risk in youth, and just how slow a taper needs to be.

Investigators examine how long patients should stay on antidepressants after feeling better—and what factors matter when considering discontinuation.

Deprescribing antipsychotics is its own beast.

And it often takes more work than starting them.

This is a bonus post in my A-to-Z series from the upcoming 8th edition of the Med Fact Book.